| Product Code: ETC11944601 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Overview |
3.1 Mexico Country Macro Economic Indicators |
3.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, 2021 & 2031F |
3.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Industry Life Cycle |
3.4 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Porter's Five Forces |
3.5 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Procedure, 2021 & 2031F |
3.7 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
4 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of obesity, type II diabetes, and NASH in Mexico |
4.2.2 Growing awareness about minimally invasive endoscopic procedures for these conditions |
4.2.3 Technological advancements in endoscopy devices improving treatment outcomes |
4.3 Market Restraints |
4.3.1 High cost associated with endoscopy devices and procedures |
4.3.2 Limited reimbursement options for endoscopic treatments in Mexico |
5 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Trends |
6 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Types |
6.1 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Product, 2021 - 2031F |
6.1.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscope, 2021 - 2031F |
6.1.4 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Mechanical endoscopic equipment, 2021 - 2031F |
6.1.5 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Visualization and documentation systems, 2021 - 2031F |
6.1.6 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Accessories, 2021 - 2031F |
6.1.7 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Other endoscopy equipment , 2021 - 2031F |
6.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Procedure |
6.2.1 Overview and Analysis |
6.2.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric balloon, 2021 - 2031F |
6.2.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Aspiration therapy, 2021 - 2031F |
6.2.4 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Endoscopic sleeve gastroplasty, 2021 - 2031F |
6.2.5 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Gastric injection, 2021 - 2031F |
6.2.6 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Lap band surgery , 2021 - 2031F |
6.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Obesity , 2021 - 2031F |
6.3.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Type II Diabetes , 2021 - 2031F |
6.3.4 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenues & Volume, By Nonalcoholic Steatohepatitis (NASH, 2021 - 2031F |
7 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Import-Export Trade Statistics |
7.1 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Export to Major Countries |
7.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Imports from Major Countries |
8 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Key Performance Indicators |
8.1 Adoption rate of endoscopy devices for obesity, type II diabetes, and NASH procedures |
8.2 Number of healthcare facilities offering endoscopic treatments for these conditions |
8.3 Patient satisfaction and outcomes post-endoscopic procedures |
9 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Opportunity Assessment |
9.1 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Procedure, 2021 & 2031F |
9.3 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
10 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market - Competitive Landscape |
10.1 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Revenue Share, By Companies, 2024 |
10.2 Mexico Endoscopy Devices for Obesity, Type II Diabetes, and NASH Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here